1,616
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma

, , , , , & show all
Pages 1057-1064 | Received 07 Dec 2017, Accepted 20 May 2018, Published online: 02 Oct 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.